Search research articles
Contact Us
Filters
Showing results (101-110 of 124) with videos related to
Page
of 13
Sort By:
Antiviral Research
|
January 2, 2019
In vivo combination of human anti-envelope glycoprotein E2 and -Claudin-1 monoclonal antibodies for prevention of hepatitis C virus infection
Laurent Mailly, Florian Wrensch, Laura Heydmann, et al.
Nature Communications
|
July 5, 2023
Structure of engineered hepatitis C virus E1E2 ectodomain in complex with neutralizing antibodies
Matthew C Metcalf, Benjamin M Janus, Rui Yin, et al.
Nature
|
June 6, 1991
New use of BCG for recombinant vaccines
C K Stover, V F de la Cruz, T R Fuerst, et al.
Journal of Virology
|
June 1, 1996
Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara
V M Hirsch, T R Fuerst, G Sutter, et al.
Biorxiv : the Preprint Server for Biology
|
April 8, 2024
Glycoengineered recombinant alpha1-antitrypsin results in comparable <i>in vitro</i> and <i>in vivo</i> activities to human plasma-derived protein
Frances Rocamora, Sanne Schoffelen, Johnny Arnsdorf, et al.
Biotechnology and Bioengineering
|
July 1, 2026
Glycoengineered Recombinant Alpha1-Antitrypsin Results in Comparable In Vitro and In Vivo Activities to Human Plasma-Derived Protein
Frances Rocamora, Chen-Lin Hsieh, Sanne Schoffelen, et al.
Journal of Functional Biomaterials
|
January 20, 2023
Skin Vaccination with Ebola Virus Glycoprotein Using a Polyphosphazene-Based Microneedle Patch Protects Mice against Lethal Challenge
Andrey Romanyuk, Ruixue Wang, Alexander Marin, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
The conserved bridging domain on HCV E1E2 glycoprotein complex is targeted by neutralizing antibodies from diverse lineages
Fang Chen, Yen Thi Kim Nguyen, Yi-Zong Lee, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1996
Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates
B Moss, M W Carroll, L S Wyatt, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 9, 2022
Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidate
Ruixue Wang, Saori Suzuki, Johnathan D Guest, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 124) with videos related to
Sort By:
Page
of 13
Antiviral Research
|
January 2, 2019
In vivo combination of human anti-envelope glycoprotein E2 and -Claudin-1 monoclonal antibodies for prevention of hepatitis C virus infection
Laurent Mailly, Florian Wrensch, Laura Heydmann, et al.
Nature Communications
|
July 5, 2023
Structure of engineered hepatitis C virus E1E2 ectodomain in complex with neutralizing antibodies
Matthew C Metcalf, Benjamin M Janus, Rui Yin, et al.
Nature
|
June 6, 1991
New use of BCG for recombinant vaccines
C K Stover, V F de la Cruz, T R Fuerst, et al.
Journal of Virology
|
June 1, 1996
Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara
V M Hirsch, T R Fuerst, G Sutter, et al.
Biorxiv : the Preprint Server for Biology
|
April 8, 2024
Glycoengineered recombinant alpha1-antitrypsin results in comparable <i>in vitro</i> and <i>in vivo</i> activities to human plasma-derived protein
Frances Rocamora, Sanne Schoffelen, Johnny Arnsdorf, et al.
Biotechnology and Bioengineering
|
July 1, 2026
Glycoengineered Recombinant Alpha1-Antitrypsin Results in Comparable In Vitro and In Vivo Activities to Human Plasma-Derived Protein
Frances Rocamora, Chen-Lin Hsieh, Sanne Schoffelen, et al.
Journal of Functional Biomaterials
|
January 20, 2023
Skin Vaccination with Ebola Virus Glycoprotein Using a Polyphosphazene-Based Microneedle Patch Protects Mice against Lethal Challenge
Andrey Romanyuk, Ruixue Wang, Alexander Marin, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
The conserved bridging domain on HCV E1E2 glycoprotein complex is targeted by neutralizing antibodies from diverse lineages
Fang Chen, Yen Thi Kim Nguyen, Yi-Zong Lee, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1996
Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates
B Moss, M W Carroll, L S Wyatt, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 9, 2022
Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidate
Ruixue Wang, Saori Suzuki, Johnathan D Guest, et al.
Page
of 13